BiomX Inc.(PHGE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PHGE BiomX Inc.

已收盘 04-15 16:00:00 EDT

1.93

-0.28

-12.67%

盘后1.95

+0.02+1.04%

19:59 EDT

最高2.22	最低1.88	成交量21.89万
今开2.22	昨收2.21	日振幅15.38%
总市值1,263万	流通市值1,172万	总股本654.35万
成交额43.35万	换手率3.61%	流通股本607.11万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PHGE","market":"US","secType":"STK","nameCN":"BiomX Inc.","latestPrice":1.93,"timestamp":1776283200000,"preClose":2.21,"halted":0,"volume":218895,"hourTrading":{"tag":"盘后","latestPrice":1.95,"preClose":1.93,"latestTime":"19:59 EDT","volume":572,"amount":1112.4556,"timestamp":1776297583525,"change":0.02,"changeRate":0.010363,"amplitude":0.010363},"delay":0,"changeRate":-0.12669683257918554,"floatShares":6071100,"shares":6543500,"eps":-22.193855,"marketStatus":"已收盘","change":-0.28,"latestTime":"04-15 16:00:00 EDT","open":2.22,"high":2.22,"low":1.88,"amount":433532.49225,"amplitude":0.153846,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-22.193855,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1776326400000},"marketStatusCode":5,"adr":0,"exchange":"AMEX","adjPreClose":2.21,"preHourTrading":{"tag":"盘前","latestPrice":2.2198,"preClose":2.21,"latestTime":"08:47 EDT","volume":2073,"amount":4593.258042,"timestamp":1776257275182,"change":0.0098,"changeRate":0.004434,"amplitude":0.068371},"postHourTrading":{"tag":"盘后","latestPrice":1.95,"preClose":1.93,"latestTime":"19:59 EDT","volume":572,"amount":1112.4556,"timestamp":1776297583525,"change":0.02,"changeRate":0.010363,"amplitude":0.010363},"volumeRatio":1.518348},"requestUrl":"/m/hq/s/PHGE","defaultTab":"news","newsList":[{"id":"1122559827","title":"BiomX Inc.交易对价包含可转换票据及认股权证，转换或行权价均为每股12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1122559827","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122559827?lang=zh_cn&edition=full","pubTime":"2026-03-31 22:52","pubTimestamp":1774968740,"startTime":"0","endTime":"0","summary":"BiomX Inc.近期披露的交易方案显示，其并购对价组合包含可转换票据与认股权证。根据条款设计，两类金融工具的转换或行权价格均设定为每股12美元。这一结构既为交易提供了灵活性，也反映出交易双方对股价潜力的共识估值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHGE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169884446","title":"BiomX Inc. 获第三方信贷支持 加速全球业务拓展与运营布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1169884446","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169884446?lang=zh_cn&edition=full","pubTime":"2026-03-31 22:52","pubTimestamp":1774968738,"startTime":"0","endTime":"0","summary":"生物制药公司BiomX Inc.近日宣布，已与第三方机构达成信贷协议，获得专项信用额度支持。此项融资将主要用于优化公司日常运营资金结构，并为跨地域业务扩张提供战略资源保障。\n通过此次信贷安排，BiomX将进一步加强其在全球多个关键市场的运营能力，推动微生物组技术平台的商业化进程。信贷资源的注入有望提升企业财务灵活性，助力公司加速实现长期增长目标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PHGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107310685","title":"BiomX签署非约束性意向书 获以色列先进空中灭火系统独家经销权","url":"https://stock-news.laohu8.com/highlight/detail?id=1107310685","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107310685?lang=zh_cn&edition=full","pubTime":"2026-03-26 20:50","pubTimestamp":1774529412,"startTime":"0","endTime":"0","summary":"生物制药公司BiomX Inc.宣布与独立第三方签订非约束性意向书，将取得先进空中灭火系统在以色列地区的独家分销权限。该协议标志着公司业务多元化战略的重要进展，为拓展消防科技领域奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHGE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154801017","title":"BiomX在以色列设立安全子公司 初始运营投资超300万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1154801017","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154801017?lang=zh_cn&edition=full","pubTime":"2026-03-26 20:49","pubTimestamp":1774529351,"startTime":"0","endTime":"0","summary":"生物制药公司BiomX Inc.宣布在以色列正式成立专注于安全领域的子公司，该公司计划为其初期运营投入超过300万美元资金。此举标志着企业正通过设立专业分支机构强化特定业务板块的战略布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHGE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166230854","title":"BiomX任命Michael Oster担任首席执行官，David Rokach担任首席财务官，共同推动下一阶段增长","url":"https://stock-news.laohu8.com/highlight/detail?id=1166230854","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166230854?lang=zh_cn&edition=full","pubTime":"2026-03-09 21:06","pubTimestamp":1773061598,"startTime":"0","endTime":"0","summary":"BiomX Inc.宣布任命Michael Oster为公司首席执行官，David Rokach为首席财务官。此次高层人事变动旨在强化公司管理团队，为下一阶段的业务拓展和战略增长提供支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PHGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614175747","title":"Biomx Inc.盘中异动 大幅下挫5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614175747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614175747?lang=zh_cn&edition=full","pubTime":"2026-02-25 00:10","pubTimestamp":1771949416,"startTime":"0","endTime":"0","summary":"北京时间2026年02月25日00时10分，Biomx Inc.股票出现异动，股价快速跳水5.49%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602250010169541d81a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602250010169541d81a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612666382","title":"Biomx Inc.盘中异动 早盘股价大涨5.90%报5.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612666382","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612666382?lang=zh_cn&edition=full","pubTime":"2026-02-19 22:32","pubTimestamp":1771511558,"startTime":"0","endTime":"0","summary":"北京时间2026年02月19日22时32分，Biomx Inc.股票出现异动，股价快速上涨5.90%。截至发稿，该股报5.56美元/股，成交量4586股，换手率0.29%，振幅0.57%。Biomx Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219223238a4b3978d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219223238a4b3978d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607073285","title":"Biomx Inc.盘中异动 股价大跌6.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607073285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607073285?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:35","pubTimestamp":1769783719,"startTime":"0","endTime":"0","summary":"北京时间2026年01月30日22时35分，Biomx Inc.股票出现异动，股价大幅下挫6.38%。截至发稿，该股报6.60美元/股，成交量3.1921万股，换手率2.09%，振幅9.93%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130223519a6c0aeb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130223519a6c0aeb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605735444","title":"Biomx Inc.盘中异动 快速拉升5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605735444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605735444?lang=zh_cn&edition=full","pubTime":"2026-01-22 23:19","pubTimestamp":1769095150,"startTime":"0","endTime":"0","summary":"北京时间2026年01月22日23时19分，Biomx Inc.股票出现波动，股价快速上涨5.23%。截至发稿，该股报3.22美元/股，成交量2.4134万股，换手率1.58%，振幅9.47%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为1.04%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122231910953df11b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122231910953df11b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605644014","title":"Biomx Inc.盘中异动 急速拉升8.00%报2.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605644014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605644014?lang=zh_cn&edition=full","pubTime":"2026-01-21 22:36","pubTimestamp":1769006160,"startTime":"0","endTime":"0","summary":"北京时间2026年01月21日22时36分，Biomx Inc.股票出现波动，股价快速上涨8.00%。截至发稿，该股报2.97美元/股，成交量3801股，换手率0.25%，振幅3.33%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121223600a69cc1b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121223600a69cc1b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593495428","title":"Biomx Inc.盘中异动 股价大涨5.02%报2.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593495428","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593495428?lang=zh_cn&edition=full","pubTime":"2025-12-23 23:07","pubTimestamp":1766502426,"startTime":"0","endTime":"0","summary":"北京时间2025年12月23日23时07分，Biomx Inc.股票出现波动，股价快速拉升5.02%。截至发稿，该股报2.30美元/股，成交量1.6714万股，换手率1.09%，振幅7.45%。Biomx Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223230707a46f73b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223230707a46f73b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110392234","title":"BiomX Inc.收到FDA有关第三方雾化器设备的进一步问询，设备用于Bx004的给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1110392234","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110392234?lang=zh_cn&edition=full","pubTime":"2025-11-26 05:42","pubTimestamp":1764106953,"startTime":"0","endTime":"0","summary":"BiomX Inc.收到FDA有关第三方雾化器设备的进一步问询，设备用于Bx004的给药","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHGE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150199749","title":"BiomX Inc.：与设备制造商紧密合作，汇总机构对Bx004的剩余信息要求","url":"https://stock-news.laohu8.com/highlight/detail?id=1150199749","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150199749?lang=zh_cn&edition=full","pubTime":"2025-11-26 05:42","pubTimestamp":1764106951,"startTime":"0","endTime":"0","summary":"BiomX Inc.：与设备制造商紧密合作，汇总机构对Bx004的剩余信息要求","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHGE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586280365","title":"Biomx Inc.盘中异动 早盘急速跳水5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586280365","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586280365?lang=zh_cn&edition=full","pubTime":"2025-11-25 22:33","pubTimestamp":1764081238,"startTime":"0","endTime":"0","summary":"北京时间2025年11月25日22时33分，Biomx Inc.股票出现异动，股价大幅下跌5.20%。截至发稿，该股报5.20美元/股，成交量1620股，换手率0.11%，振幅1.73%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125223358977ec8b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125223358977ec8b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583159639","title":"Biomx Inc.盘中异动 早盘股价大涨5.03%报0.368美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583159639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583159639?lang=zh_cn&edition=full","pubTime":"2025-11-14 23:11","pubTimestamp":1763133108,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日23时11分，Biomx Inc.股票出现波动，股价急速拉升5.03%。截至发稿，该股报0.368美元/股，成交量25.2091万股，换手率0.95%，振幅5.63%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114231148a6f9d533&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114231148a6f9d533&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582347259","title":"Biomx Inc.盘中异动 大幅拉升5.17%报0.411美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582347259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582347259?lang=zh_cn&edition=full","pubTime":"2025-11-12 02:08","pubTimestamp":1762884492,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日02时08分，Biomx Inc.股票出现波动，股价快速上涨5.17%。截至发稿，该股报0.411美元/股，成交量65.1235万股，换手率2.45%，振幅4.68%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为1.56%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511120208139762f993&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511120208139762f993&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581729157","title":"Biomx Inc.盘中异动 股价大跌8.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581729157","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581729157?lang=zh_cn&edition=full","pubTime":"2025-11-04 22:31","pubTimestamp":1762266666,"startTime":"0","endTime":"0","summary":"北京时间2025年11月04日22时31分，Biomx Inc.股票出现异动，股价大幅跳水8.07%。Biomx Inc.股票所在的生物技术行业中，整体跌幅为0.88%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104223106a6e0b544&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104223106a6e0b544&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127250552","title":"BiomX：预计不再进行额外的非临床研究，FDA对CMC的意见与现有的制造与质量战略一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1127250552","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127250552?lang=zh_cn&edition=full","pubTime":"2025-11-04 21:42","pubTimestamp":1762263733,"startTime":"0","endTime":"0","summary":"BiomX：预计不再进行额外的非临床研究，FDA对CMC的意见与现有的制造与质量战略一致","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PHGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152750377","title":"BiomX宣布获得FDA积极反馈，支持其用于糖尿病足感染的下一代噬菌体鸡尾酒项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1152750377","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152750377?lang=zh_cn&edition=full","pubTime":"2025-11-04 21:41","pubTimestamp":1762263678,"startTime":"0","endTime":"0","summary":"BiomX宣布获得FDA的积极反馈，支持其针对糖尿病足感染的下一代噬菌体鸡尾酒项目。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHGE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187953494","title":"BiomX提供项目更新并宣布新的FDA反馈，可能扩展Bx004的开发路径","url":"https://stock-news.laohu8.com/highlight/detail?id=1187953494","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187953494?lang=zh_cn&edition=full","pubTime":"2025-10-17 20:31","pubTimestamp":1760704270,"startTime":"0","endTime":"0","summary":"BiomX提供项目更新并宣布新的FDA反馈，可能扩展Bx004的开发路径","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHGE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biomx.com","stockEarnings":[{"period":"1week","weight":-0.2584},{"period":"1month","weight":-0.643},{"period":"3month","weight":-0.1629},{"period":"6month","weight":-0.8031},{"period":"1year","weight":-0.7915},{"period":"ytd","weight":0.1818}],"compareEarnings":[{"period":"1week","weight":0.0535},{"period":"1month","weight":0.0486},{"period":"3month","weight":0.0059},{"period":"6month","weight":0.0512},{"period":"1year","weight":0.2881},{"period":"ytd","weight":0.0184}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BiomX Inc.于2017年11月1日根据特拉华州法律成立。2019年10月28日，该公司与BiomX Ltd.合并，然后更名为BiomX Inc.。该公司正在开发天然和工程化的噬菌体混合物，旨在针对和消灭慢性疾病中的有害细菌，目前主要致力于囊性纤维化，并在较小程度上致力于特应性皮炎。该公司发现并验证专有细菌靶点，并针对这些靶点定制噬菌体组合物。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.415936},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.05055},{"month":3,"riseRate":0.285714,"avgChangeRate":0.093076},{"month":4,"riseRate":0.375,"avgChangeRate":-0.097188},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.104594},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.042142},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.028521},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.072801},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.126957},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.11497},{"month":11,"riseRate":0.142857,"avgChangeRate":-0.17671},{"month":12,"riseRate":0.571429,"avgChangeRate":-0.097259}],"exchange":"AMEX","name":"BiomX Inc.","nameEN":"BiomX Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.41.0","shortVersion":"4.41.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BiomX Inc.(PHGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BiomX Inc.(PHGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BiomX Inc.,PHGE,BiomX Inc.股票,BiomX Inc.股票老虎,BiomX Inc.股票老虎国际,BiomX Inc.行情,BiomX Inc.股票行情,BiomX Inc.股价,BiomX Inc.股市,BiomX Inc.股票价格,BiomX Inc.股票交易,BiomX Inc.股票购买,BiomX Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BiomX Inc.(PHGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BiomX Inc.(PHGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}